cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay
K-Number: K160571 · 2016-12-19
Device Summary
Frequently Asked Questions
What is the cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay?
cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay is a medical device that received FDA 510(k) clearance on 2016-12-19. It is manufactured by Roche Diagnostics Operations (Rdo). The 510(k) number is K160571.
When was cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay approved by the FDA?
cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay received FDA 510(k) clearance on 2016-12-19, under approval number K160571.
What company makes cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay?
cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay is manufactured by Roche Diagnostics Operations (Rdo).
What is the FDA product code for cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay?
The FDA product code for cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay is PDJ.
Related PubMed Literature
Other Devices by Roche Diagnostics Operations (Rdo)
Related Devices (Code: PDJ)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.